Appellate Court Rules Against Patients in Gene Patent Suit
A group of advocates, led by the American Civil Liberties Union, has lost its appeal in the gene patent suit. Myriad Genetics has patented the BRCA1 and BRCA2 mutations, which are linked to breast and ovarian cancers. The suit contends that because these mutations are naturally occurring, they are not patentable.
Read more at the ACLU’s web page